Tuesday, November 5, 2024

Specialty Networks Unveils the PPS Analytics Platform for Rheumatology to Enhance Patient Care and Practice Efficiency

Related stories

Absci and Twist Bioscience Collaborate to Design Novel Antibody using Generative AI

Absci Corporation a data-first generative AI drug creation company, and...

GreyNoise Intelligence Discovers Zero-Day Vulnerabilities in Live Streaming Cameras with the Help of AI

GreyNoise Intelligence, the cybersecurity company providing real-time, verifiable threat...

Medidata Launches Bundled Solutions to Support Oncology and Vaccine Trials

Medidata, a Dassault Systèmes brand and leading provider of...

Blend Appoints Mike Mischel as SVP of AI Consulting

Blend, a leader in data science and AI-powered solutions,...

Patronus AI Launches Industry-First Self-Serve API for AI Evaluation and Guardrails

Patronus AI announced the launch of the Patronus API, the first...
spot_imgspot_img

The PPS Analytics platform allows physicians to identify and navigate patients based on personalized pathways and protocols, leading to clinical and economic value creation for independent physician practices.

Specialty Networks, a provider of urology, gastroenterology, and rheumatology care performance and population management solutions for community-based specialty practices, has launched their technology and services platform, PPS Analytics, to United Rheumatology members. United Rheumatology was acquired by Specialty Networks in 2022.

PPS Analytics is an AI-enabled technology platform designed to help identify, navigate, and engage patients to improve adherence to clinical care pathways and protocols for diagnostics and therapeutic interventions. Additional applications include identifying patients for clinical trials or RWE study participation, enrolling patients in Principal or Chronic Care Management Programs, and identifying patients for in-house dispensing (IODs) or infusion therapies.

“The voice of our members has always guided us towards building innovative technology and tech-enabled solutions that create meaningful positive impact on patient outcomes,” said Shailendra Sharma, CEO of Specialty Networks. “We see a huge need for real-world data and AI-enabled technologies to assist independent rheumatology practices. These technologies are needed to identify, navigate, and engage their patients in pathway-driven, therapeutic, diagnostic and follow-up care interventions. We are quite excited to launch PPS Analytics to our United Rheumatology member practices.”

Also Read: Enhatch Announces FDA Clearance for a TKA Patient Specific Instrumentation System with AI-Assisted Segmentation and Treatment Planning

Backed by Clinical and Industry Experts­­­
PPS Analytics has been available to urology and uro-oncology practices for almost 10 years. Today, the PPS technology serves almost 3,000 urologists in their independent physician practices, providing actionable intelligence for several million patients who are being actively cared for by those physicians each year.

The launch of PPS Analytics for Rheumatology marks an exciting milestone for Specialty Networks and would not have been possible without the thought leadership and guidance from our respected Medical Policy Committee (MPC) members. MPC members advised PPS to aid in the development of unique AI algorithms to gain the most benefit from the real-world data that resides in electronic medical records, practice management, and other systems.

SOURCE: PRNewswire

Subscribe

- Never miss a story with notifications


    Latest stories

    spot_img